---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006906"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:14:47.517585+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PAVmed distributes 3.33M Lucid Diagnostics shares as special dividend; warrant price adjusted

## Summary
- PAVmed distributed 3,331,747 shares of Lucid Diagnostics common stock as a special pro rata dividend to common and preferred stockholders.
- Each PAVmed share entitled to 0.37709668 Lucid Diagnostics shares based on record date January 15, 2024.
- After distribution, PAVmed retains approx. 65.2% ownership of Lucid Diagnostics; 6.9% distributed.
- Exercise price of Series Z Warrants reduced from $24.00 to $23.48 per share due to dividend fair value of $0.52.
- Senior convertible note holders waived participation in the distribution; no fractional shares issued.

## SEC filing metadata
- accession: 0001493152-24-006906
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 8.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315224006906/0001493152-24-006906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315224006906/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006906
- JSON: https://secwatch.observer/filing/0001493152-24-006906.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006906.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.